Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

ClinicalTrials.gov ID: NCT01602120

Public ClinicalTrials.gov record NCT01602120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Lampalizumab (FCFD4514S) in Patients With Geographic Atrophy Who Have Completed Genentech-Sponsored Lampalizumab Studies

Study identification

NCT ID
NCT01602120
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

  • Lampalizumab Drug

Drug

Eligibility (public fields only)

Age range
60 Years to 89 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 28, 2012
Primary completion
Nov 7, 2017
Completion
Feb 8, 2018
Last update posted
Sep 10, 2019

2012 – 2018

United States locations

U.S. sites
41
U.S. states
23
U.S. cities
40
Facility City State ZIP Site status
Retina Centers P.C. Tucson Arizona 85704
Retina-Vitreous Assoc Med Grp Beverly Hills California 90211
Retinal Diagnostic Center Campbell California 95008
The Retina Partners Encino California 91436
Loma Linda University Loma Linda California 92354
San Diego Retina Associates Oceanside California 92056
W Coast Retina Med Group Inc San Francisco California 94107
West Coast Retina San Francisco California 94107
California Retina Consultants Santa Barbara California 93103
Retina Macula Institute Torrance California 90503
Colorado Retina Associates, PC Golden Colorado 80401
Retina Group of Florida Boca Raton Florida 33431
National Ophthalmic Research Institute Fort Myers Florida 33912
Florida Eye Associates Melbourne Florida 32901
Retina Care Specialists Palm Beach Gardens Florida 33410
Retina Specialty Institute Pensacola Florida 32503
Ctr for Retina & Macular Dis Winter Haven Florida 33880
Southeast Retina Center Augusta Georgia 30909
Wolfe Eye Clinic West Des Moines Iowa 50266
Elman Retina Group Baltimore Maryland 21237
Ophthalmic Consultants of Boston Boston Massachusetts 02114
Vitreoretinal Surgery Edina Minnesota 55435
The Retina Institute St Louis Missouri 63128
Sierra Eye Associates Reno Nevada 89502
Eye Associates of New Mexico Albuquerque New Mexico 87102
Opthalmic Consultants of LI Lynbrook New York 11563
Western Carolina Retinal Associate PA Asheville North Carolina 28803
Char Eye Ear &Throat Assoc Charlotte North Carolina 28210
Retina Assoc of Cleveland Inc Beachwood Ohio 44122
Cincinnati Eye Institute Cincinnati Ohio 45242
Dean McGee Eye Institute Oklahoma City Oklahoma 73099
Retina Northwest Portland Oregon 97221
Mid Atlantic Retina Philadelphia Pennsylvania 19107
Charleston Neuroscience Institute Ladson South Carolina 29456
Southeastern Retina Associates Knoxville Tennessee 37923
Tennessee Retina PC Nashville Tennessee 37203
W Texas Retina Consultants PA Abilene Texas 79606
Retina Research Center Austin Texas 78705
Texas Retina Associates Dallas Texas 75231
Wagner Macula & Retina Center Norfolk Virginia 23451
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01602120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 10, 2019 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01602120 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →